Current issues in treatment of patients with combination of rosacea subtypes

Abstract

Relevance. Rosacea is a chronic skin syndrome that encompasses various combinations of potential signs and symptoms. Global epidemiological studies have found that 5.46% of the adult population suffers from rosacea. Combined methods (drugs and hardware methods, including lasers) in the treatment of rosacea have a high potential. Relevant is the study of the effectiveness of ivermectin and laser technologies in patients with a combination of subtypes of rosacea.Material and methods. 36 patients with a combination of rosacea subtypes were under observation. Depending on the therapy, the patients were divided into two groups: group 1 (18 patients) – patients received neodymium laser procedures and topical therapy with ivermectin, group 2 (16 patients) – topical therapy using ivermectin. Efficiency was assessed using visioscanning, taking into account the dermatological index GSS (Global Severity Score), the dermatological index of the scale of symptoms (DISHS).Research results. According to the total index of DISH after 2 months, the highest efficiency in stopping both inflammation and the vascular component was observed in group 1 (75.2%), somewhat lower – in group 2 (49.5%). month, the total DISH index in group 1 decreased by 85.1%, while in group 2 – by 58.5%, after 6 months the total DISH index in group 1 decreased by 91.5%, while in group 2 group – by 65.6%.Conclusions. The combined use of neodymium laser and ivermectin is a highly effective and safe method of therapy in patients with a combination of erythematotelangiectatic and papulopustular rosacea subtypes.